..............page:267-271
..............page:185-186
..............page:228-229,236
..............page:206-212
..............page:253-256
..............page:190-192,198
..............page:187-189
Advances in studies on brucine
xu jin-hua; chen jun; cai bao-chang(nanjing university of chinese medicine; jiangsu key laboratory of chinese medicine processing; nanjing 210029; china)
..............page:213-216,221
..............page:234-236
Effect of agmatine on alcohol-drinking behavior in alcohol-preferring FH/Wjd rats
jing li1; qiu yi1; zhang min1; wang wei-ping1; chen feng2; andrew j lawrence3; li jin4; liang jian-hui1(1 national institute on drug dependence; peking university; beijing 100083; china; 2 school of medical sciences; rmit university; victoria 3083; australia; 3 howard florey institute; the university of melbourne; victoria 3010; australia; 4 beijing institute of toxicology and pharmacology; beijing 100850; china)
..............page:243-247
..............page:262-266,271
IL-4 cytotoxin inhibits cell growth and hormone secretion of pituitary adenomas
chen lu-kui1; 2; kang jun-long2; xu bai-nan1; liu yun-sheng3; zhang jun-qing2; tian xin-hua2(1 department of neurosurgery; pla general hospital; beijing 100853; china; 2 department of neurosurgery; zhongshan hospital; xiamen university; xiamen 361004; china; 3 department of neurosurgery; xiangya hospital; central south university; changsha 410008; china)
..............page:237-242
..............page:247,256
Effects of noradrenaline and phentolamine in the rat hepatic stellate cells
chen meng1; 2; ma yong1; 2; wei wei1; li xiang1; zhang lin3(1 institute of clinical pharmacology; anhui medical university; key laboratory of anti-inflammatory and immunopharmacology in anhui province; anhui center of engineering for antiinflammatory and immunodrugs; hefei 230032; china; 2 department of liver diseases; 123th hospital of pla; bengbu 233015; china; 3 department of epidemiology and biostatistics; school of public health; anhui medical university; hefei 230032; china)
..............page:257-261
Pharmaceutical care for the patients with cerebral infarction
liu miao1; 2; zhao rong-sheng1(1 department of pharmacy; peking university third hospital; beijing 100083; china; 2 department of pharmacyadministration and clinical pharmacy; school of pharmaceutical sciences; peking university; beijing 100083; china)
..............page:277-280
..............page:193-198
..............page:272-276
..............page:230-233
..............page:202-205
..............page:248-252
..............page:217-221
..............page:225-227
Efficacy of compound enalapril and compound valsartan in patients with mild and moderate primary hypertension
wang li1; huang yan1; wang fang2; cheng xiao-ru1; he qi-ming3; pang hui-ming1; bian wen-yan1; li yi-shi1(1 key laboratory of clinical research of cardiovascular drug; department of clinical pharmacology; cardiovascular institute and fuwai hospital; peking union medical college & chinese academy medical sciences; beijing 100037; china; 2 department of cardiocology; beijing hospital; beijing 100730; china; 3 shougang hospital; beijing university; beijing 100041; china)
..............page:222-224,261
..............page:199-201,205